Minimal Change Disease Induced by Lorlatinib

J Thorac Oncol. 2018 Aug;13(8):e154-e156. doi: 10.1016/j.jtho.2018.03.033.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma of Lung / drug therapy
  • Female
  • Humans
  • Lactams, Macrocyclic / adverse effects*
  • Lung Neoplasms / drug therapy
  • Middle Aged
  • Nephrosis, Lipoid / chemically induced*
  • Nephrosis, Lipoid / pathology

Substances

  • Lactams, Macrocyclic
  • lorlatinib